Tag Archives: patent attorney

Federal Circuit Throws a Wrench into “Mechanism of Action” Claims

A three-judge panel of the Court of Appeals for the Federal Circuit recently decided Ariad Pharmaceuticals, Inc. et al. v. Eli Lilly & Company, appeal no. 2008-1248 (Fed. Cir. April 3, 2009), involving Blatimore et al. (U.S. Pat. No. 6,410,516). … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , , , , | Leave a comment

Kubin Analysis Continued

My last post began a rather selective analysis of In re Kubin, which the Federal Circuit decided on April 3, 2009 (see previous post for citations to this and related decisions). Kubin’s claims to DNA molecules encoding sequences including that … Continue reading

Posted in Obviousness | Tagged , , , , , , , , , , | Leave a comment

Why A Blog? Why Me? Why You?

I started this blog to begin a conversation about patent law and policy, particularly how it affects those of us involved in “prep/pros” and, more particularly, how it affects examination policy and practice in the USPTO. This blog will have … Continue reading

Posted in Miscellaneous | Tagged , , , , , , , , , | Leave a comment